@article{ref1,
title="Low-dose venlafaxine in three adolescents and young adults with autistic disorder improves self-injurious behavior and attention deficit/hyperactivity disorders (ADHD)-like symptoms",
journal="Progress in neuro-psychopharmacology and biological psychiatry",
year="2006",
author="Carminati, Giuliana Galli and Deriaz, Nicolas and Bertschy, G.",
volume="30",
number="2",
pages="312-315",
abstract="In our clinical practice, we have had good experiences with venlafaxine in the treatment of self-injurious behavior (SIB) and attention deficit/hyperactivity disorders (ADHD)-like symptoms in patients with pervasive developmental disorders (PDD), and we report here three cases of possible therapeutic response: (A) a 17-year-old boy with autism and severe behavioral symptoms, including aggression toward self or property, SIB and hyperactivity, who appeared to respond to low-dose venlafaxine (18.75 mg/day); (B) a 23-year-old woman with autism hyperactivity who appeared to respond to low-dose venlafaxine (18.75 mg/day); (C) a 17-year-old girl with autism hyperactivity who appeared to respond to low-dose venlafaxine (18.75 mg/day). Follow-ups occurred respectively 18, 36 and 6 months after treatment initiation, making it possible to observe the stability of the clinical improvement in these cases.<p /> <p>Language: en</p>",
language="en",
issn="0278-5846",
doi="10.1016/j.pnpbp.2005.10.002",
url="http://dx.doi.org/10.1016/j.pnpbp.2005.10.002"
}